查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1840801

胃腸病學門診手術中心市場（按服務、適應症、治療水平、患者人口統計、應用、最終用戶和所有者分類）——2025-2032 年全球預測

Gastroenterology Ambulatory Surgery Center Market by Services, Indication, Level of Care, Patient Demographic, Application, End-User, Ownership - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，胃腸病學門診手術中心市場將成長 135.5 億美元，複合年成長率為 8.49%。

主要市場統計數據
基準年2024年 70.5億美元
預計2025年 76.6億美元
預測年份：2032年 135.5億美元
複合年成長率（%） 8.49%

門診消化內科手術中心簡介：強調臨床範圍和操作的多樣性以及以患者為中心的服務的演變

在臨床創新、患者對便利性的偏好以及簡化的護理路徑的推動下，胃腸門診手術中心 (ASC) 模式正在重塑診斷和治療程序的交付。近年來，內視鏡技術、微創手術技術和手術全期管理的進步擴大了可在門診安全實施的手術範圍。因此，專業的胃腸病學機構正在發展成為高容量的樞紐，提供頻譜的膠囊內視鏡檢查、大腸鏡檢查以及上下消化道手術，同時保持精簡的觀察和當日手術服務。

它們以多種形式營運，包括診所、醫生辦公室、醫院附屬單位和獨立的 ASC，所有權模式也從公司所有平台到獨立和醫院附屬中心不等。患者群體涵蓋兒童、成人和老年人，需要量身定做的臨床通訊協定、復健途徑和手術全期支持。此外，診斷測試、內視鏡檢查和治療性介入（例如內視鏡黏膜切除術和黏膜下剝離術）擴大在傳統住院環境之外進行。胃腸病 ASC 將這些功能與以患者為中心的設計相結合，是現代醫療保健服務的重要組成部分，提供高價值、低成本的替代方案，並專注於吞吐量、安全性和患者體驗。

臨床創新、報銷變化和勞動力動態如何加速門診胃腸病學護理的轉型

在技​​術創新、醫療服務模式革新和員工團隊不斷發展的推動下，胃腸道門診手術中心的格局正在改變。高解析度影像、膠囊內視鏡和新一代內視鏡正在提高診斷效率，而內視鏡黏膜切除術、黏膜下剝離術和精細切除術等先進治療方案則正在擴大當日手術的範圍。同時，隨著圍手術期方案和麻醉技術縮短患者恢復時間，腹腔鏡胃腸手術、括約肌切開術和疝氣修補術等手術全期手術方法正在轉移到門診平台。

支付改革和基於價值的合約正在加速低訪問量、高容量手術從住院醫院向獨立醫療服務中心 (ASC) 和診所環境的遷移，獎勵醫療機構的最佳化。遠端醫療和遠距術前評估工具正在提高診療效率並降低爽約率，而整合的電子健康記錄和程序分析則實現了持續的品質改進和即時病例管理。勞動力動態，尤其是對接受過高級內視鏡培訓的臨床醫生、手術全期護理師和專業技術人員的需求，正在推動對培訓和保留計畫的投資。最後，患者對便利性、透明度和快速訪問的期望加劇了競爭，迫使醫療機構透過護理協調、當日手術途徑和增強型復健通訊協定來實現差異化。

評估 2025 年關稅趨勢對門診胃腸病服務和資本規劃的累積營運和採購影響

2025 年關稅和貿易相關政策的變化為胃腸外科 ASC 的供應鏈、資本規劃和籌資策略帶來了新的考慮因素。許多診斷和治療設備、耗材和內視鏡配件依賴全球製造網路，進口關稅的增加和貿易摩擦可能會增加購買成本並導致前置作業時間的變化。對於專注於資本密集型升級（例如購買先進的內視鏡和微創手術系統）的醫療保健組織來說，關稅帶來的成本壓力要求重新評估更換週期、租賃與購買決策以及總擁有成本的評估。

累積影響不僅限於設備成本，還延伸至庫存管理和合約行為。醫療機構正在透過多元化供應商組合、協商固定價格、多年期合約以及探索區域製造夥伴關係來降低風險。與大型醫院系統相比，獨立的醫療服務中心 (ASC) 通常採購規模較小，它們可能會尋求集團採購或策略聯盟來恢復談判優勢。同時，與關稅相關的價格上漲可能會加速那些尋求擴大營運規模以吸收成本衝擊的機構之間的整合。無法跟上不斷上漲的投入成本的報銷框架將給報銷額較低的門診手術帶來利潤壓力，促使領導者最佳化病例組合、加強編碼和文檔實踐，並尋求符合付款人優先事項的更高價值治療性介入。最終，在關稅不確定性的環境下，策略性和差異化的供應鏈反應，結合積極主動的財務建模，對於維持服務的連續性和持續的創新投資至關重要。

綜合細分分析揭示了胃腸外科 ASC 的服務類型、護理水平和所有權模式如何決定策略重點

細緻的細分視角揭示了胃腸外科ASC領域中臨床機會與營運重點的交會點。按服務進行分析，診斷能力涵蓋膠囊內視鏡、大腸鏡、食道內視鏡、軟性乙狀結腸鏡和上消化道內視鏡等，提供高通量工作流程，支援早期發現和簡化轉診。同時，內視鏡黏膜切除術、內視鏡黏膜下剝離術、痔瘡結紮術、息肉切除術和硬化療法等治療服務，創造了明確的門診治療途徑，從而減少住院治療。

大腸直腸癌篩檢、胃腸道感染疾病、發炎性腸道疾病和肝硬化的優先排序分別需要不同的診斷演算法、術前和術後風險分層以及術後追蹤。護理水平軸——觀察與當日手術——決定了人員配置模式、恢復室設計和排程方法，以在確保病人安全的同時最大限度地提高診療效率。兒科患者需要適合年齡的鎮靜和以家庭為中心的工作流程；成人患者需要篩檢和慢性病管理；老年患者需要強化的術前評估和恢復通訊協定，並考慮到併發症。

應用主導的細分進一步明確了診斷檢測、內視鏡實驗室和治療性介入之間的資源分配，從而影響資本投資重點和臨床能力發展。診所/診所、醫院和獨立醫療服務中心 (ASC) 之間的最終用戶差異決定了轉診流程、病例複雜性以及與付款人和供應商的談判能力。最後，所有權結構（企業自有平台、獨立中心或醫院附屬單位）會影響策略方向，包括成長、規模和整合。每種結構在資本取得、營運自主權和臨床通訊協定標準化能力方面都有所權衡。這些細分視角提供了一個全面的框架，用於將臨床服務與財務策略和患者需求相結合。

對美洲、歐洲、中東、非洲和亞太地區報銷和能力建設的區域動態進行比較和戰略考慮

區域動態顯著影響全球的營運模式、先進流程採用曲線和監管合規要求。在美洲，成熟的報銷基礎設施和強勁的門診病人轉型趨勢，推動著專注於內視鏡檢查的ASC和獨立外科中心的快速發展，尤其注重結直腸癌篩檢計畫和注重效率的當日手術工作流程。北美中心通常利用整合採購和成熟的認證框架來標準化品質並降低單次手術成本，市場參與企業正在探索捆綁支付安排並與付款人網路合作。

在歐洲、中東和非洲，報銷系統和監管要求的差異導致採用率參差不齊。西歐體系通常強調整合護理路徑和公私合營，使附設醫院的ASC能夠擴展診斷和治療內視鏡計畫。相較之下，該地區的新興市場為能力建設、技術轉移以及對發炎性腸道疾病管理和胃腸道感染控制等高影響力服務的定向投資提供了機會。監管差異也會影響設備註冊時間表和跨境籌資策略。

受選擇性治療需求成長、人口老化以及私人醫療基礎設施不斷擴張的推動，亞太地區正在快速普及微創和內視鏡治療技術。一些國家已加強本地製造能力，降低國際貿易中斷帶來的風險，並支持競爭性定價。然而，臨床醫生培訓、報銷改革以及城鄉醫療可近性差距仍然存在。有效擴大門診胃腸病學治療需要獨特的策略，將人力資源開發、基於遠端醫療的分診和分階段的資金部署相結合。

推動創新和規模發展的設備製造商、ASC 營運商和綜合醫療系統之間的競爭動態和夥伴關係策略

門診胃腸病學服務的競爭格局由設備製造商、技術創新者、ASC營運商和透過夥伴關係追求臨床差異化和規模化的綜合醫療系統決定。設備和耗材供應商優先考慮一次性產品，這些產品不僅耐用、影像清晰、吞吐量經濟，還能降低交叉污染的風險。供應商將硬體與分析、遠端監控和服務等級協定結合，為ASC營運商提供最佳化運作和程序效率的工具。

為因應這項挑戰，ASC營運商和醫療系統正與技術合作夥伴攜手合作，進行有針對性的收購以擴大地域覆蓋範圍，並投資於能夠集中處理複雜內視鏡手術的卓越中心模式。策略性買家也專注於垂直整合機會，例如整合門診網路，該網路包含術前評估平台、集中調度和標準化臨床通訊協定，旨在推動一致性和規模經濟。新的服務模式強調醫生團體與企業之間的合資企業，以平衡臨床控制和資金取得。在整個生態系統中，最成功的組織是那些能夠平衡臨床創新與嚴謹的營運執行，並利用供應鏈彈性、臨床醫生參與度和付款人關係來維持成長和品質的組織。

為高階主管領導提供可行的策略指南，以加強臨床能力、多樣化供應鏈並獲取門診胃腸病學護理的價值。

門診胃腸病學領導者應採取積極主動、多管齊下的策略，在降低下行風險的同時，獲得臨床和經濟價值。首先，優先投資於能夠實現高臨床效益和高操作效率的診斷和治療內視鏡技術，並輔以結構化的培訓計劃，以提高臨床醫生的能力。其次，透過多供應商承包、區域製造夥伴關係以及參與聯合採購安排，實現採購多元化，以減輕供應側衝擊和關稅相關成本波動帶來的影響。第三，透過擴展當日手術通訊協定、加強術前遠距遠端保健評估以及最佳化觀察路徑來改善服務組合和吞吐量，從而在不影響安全性的情況下減少住院時間。

此外，對於大腸癌篩檢和慢性病管理獎勵等高容量服務，應與付款方和醫療系統合作，制定基於價值的方案，將品質和成本控制激勵機制結合起來。投資整合排程、手術全期記錄和分析功能的數位基礎設施，以監控療效並識別效率提升機會。對於所有權集團，應評估合併和合資模式，以達到競爭性採購和資本取得所需的規模。最後，優先考慮患者體驗和透明度，以加強轉診關係並搶佔市場佔有率。在日益以消費者主導的世界中，清晰地溝通手術預期、恢復時間表和費用，可以使醫療中心脫穎而出。

透明的混合調查方法將一手資料和二手資料與情境分析相結合，為 ASC 提供可行的見解

本執行摘要所依據的研究結合了主要研究和次要研究，以確保其嚴謹性和有效性。主要研究包括對臨床醫生、ASC 經理、供應鏈專業人員和付款人的結構化訪談，旨在提供關於流程、採購優先順序和報銷之間相互作用的定性見解。次要研究涵蓋同行評審的臨床文獻、監管指南、設備性能文件以及支持臨床趨勢和技術能力的公開意見書。

我們的分析方法將定性觀察結果與營運指標（例如吞吐量、病例組合複雜度和資源利用率）進行三角測量，從而清晰地描繪當前的醫療實踐模式。為了突出適合每個細分市場的差異化策略，我們根據服務、適應症、護理水平、患者人口統計、應用、最終用戶和所有權結構進行了細分分析。為了進行區域比較，我們利用政策分析和採用指標來繪製美洲、歐洲、中東和非洲以及亞太地區的準備狀態。不確定性（尤其是在貿易政策和報銷變化方面），我們採用基於情境的分析來概述可行的營運應對措施和財務敏感性。我們的調查方法強調透明度、可重複性和可操作性，以便為策略決策提供參考。

為什麼策略性臨床投資和供應鏈彈性決定了胃腸外科 ASC 的長期成功

門診胃腸病中心處於臨床創新、營運工程和不斷變化的消費者期望的交匯點，既帶來了重大機遇，也帶來了獨特的執行挑戰。診斷和治療內視鏡技術的進步，加上手術全期護理的改進，使得更廣泛的手術能夠轉向當日和基於觀察的模式，從而改善了可及性並降低了醫療總成本。然而，外部壓力，包括波動的關稅、供應鏈影響以及不同的地區報銷框架，需要採取策略性應對措施，在臨床能力投資與採購慣例之間取得平衡。

成功的組織機構應使其服務組合與人群需求保持一致，投資於臨床醫生培訓和數位化工作流程，實現供應鏈多元化以保持韌性，並尋求在不犧牲臨床自主權的情況下提供資金和規模的夥伴關係結構。透過專注於以結果、患者體驗和總成本衡量的價值，醫療保健提供者可以將其門診胃腸病中心定位為擴展診斷和治療性介入的首選醫療機構。周到的執行、嚴格的品管和適應性策略將決定哪些中心能夠從門診胃腸病治療的轉變中獲益。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 先進內視鏡成像技術的快速應用將縮短手術時間並改善治療效果。
  • 整合人工智慧演算法，提高門診中心息肉檢測與診斷的準確性
  • 擴大當日出院通訊協定，輔以鎮靜劑替代品和簡化的術前評估
  • 向基於價值的報銷模式轉型，以激勵品質措施並降低胃腸病學 ASC 的再入院率
  • 實施術前和術後諮詢的遠端醫療平台可提高病患參與度和營運效率
  • 投資可攜式視鏡和移動大腸鏡檢查裝置，擴大農村和服務不足患者群體的診療覆蓋率

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

8. 胃腸病學門診手術中心市場（按服務）

  • 診斷服務
    • 膠囊內視鏡
    • 大腸鏡檢查
    • 食道測壓
    • 軟性乙狀結腸鏡檢查
    • 上消化道內視鏡檢查
  • 外科服務
    • 減重手術
    • 膽囊切除術
    • 大腸直腸手術
    • 腹股溝疝氣修補術
    • 腹腔鏡胃腸手術
    • 括約肌切開術
  • 治療服務
    • 內視鏡黏膜切除術
    • 內視鏡黏膜下剝離術
    • 痔瘡結紮術
    • 切除術
    • 硬化療法

9. 胃腸病學門診手術中心市場（按適應症）

  • 大腸癌篩檢
  • 胃腸道感染疾病
  • 發炎性腸道疾病
  • 肝硬化

10. 胃腸病學門診手術中心市場（依護理等級）

  • 觀察
  • 當日手術

第 11 章胃腸病學門診手術中心市場（依病患屬性）

  • 成人
  • 老年人
  • 孩子們

第 12 章胃腸病學門診手術中心市場（按應用）

  • 診斷測試
  • 內視鏡檢查
  • 治療性介入

第 13 章。胃腸病學門診手術中心市場（按最終用戶）

  • 診所和醫生辦公室
  • 醫院
  • 獨立 ASC

14. 胃腸病學門診手術中心市場（按所有權類型）

  • 公司所有權
  • 自主型
  • 醫院相關

15. 胃腸病學門診手術中心市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第 16 章胃腸病學門診手術中心市場（按類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 17 章。按國家/地區分類的胃腸病學門診手術中心市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Alfa Surgery Center, LLC
    • Envision Healthcare Corporation
    • GE HealthCare Technologies Inc.
    • Ontario Advanced Surgery Center
    • Tenet Healthcare Corporation
    • Universal Health Services, Inc.
    • Covenant Physician Partners
    • Regent Surgical
    • Gastro Health LLC
    • Ohio Gastroenterology Group Inc.
    • HCA Healthcare, Inc.
    • SCA Health
    • United Digestive
    • Alabama Digestive Health Endoscopy Center（AL）
    • Shelby Ambulatory Surgery
    • Baptist Health South Florida, Inc.
    • Gulf Coast Endoscopy Center
    • Jupiter Outpatient Surgery Center, LLC
    • SOUTH BROWARD ENDOSCOPY, LLC
    • The Outpatient Center of Boynton Beach
    • Liberty Endoscopy Center
    • OHIO GASTROENTEROLOGY & LIVER INSTITUTE and GASTRO HEALTH
    • Inova McLean Ambulatory Surgery Center
    • Gastroenterology Associates Endoscopy Center
    • Athens Gastroenterology Center
Product Code: MRR-B9334AD6C1A9

The Gastroenterology Ambulatory Surgery Center Market is projected to grow by USD 13.55 billion at a CAGR of 8.49% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 7.05 billion
Estimated Year [2025] USD 7.66 billion
Forecast Year [2032] USD 13.55 billion
CAGR (%) 8.49%

An incisive introduction to ambulatory gastroenterology centers highlighting clinical scope operational diversity and patient-centric service evolution

The ambulatory surgery center (ASC) model for gastroenterology is reshaping how diagnostic and therapeutic procedures are delivered, driven by clinical innovation, patient preference for convenience, and efficiencies in care pathways. In recent years, advances in endoscopic technology, minimally invasive surgical techniques, and perioperative management have expanded the range of procedures safely performed in outpatient settings. As a result, facilities that concentrate on gastroenterology are evolving into high-capacity hubs that deliver capsule endoscopy, colonoscopy, and a wide spectrum of upper and lower gastrointestinal procedures while maintaining streamlined observation and same-day surgery services.

Operational structures vary across clinics and physicians' offices, hospital-affiliated units, and independent ASCs, while ownership models range from corporation-owned platforms to freestanding and hospital-aligned centers. Patient demographics span pediatric care through adult and geriatric populations, requiring tailored clinical protocols, recovery pathways, and perioperative support. Moreover, the application landscape incorporates diagnostic tests, endoscopy procedures, and therapeutic interventions such as endoscopic mucosal resection and submucosal dissection, which are increasingly performed outside traditional inpatient settings. This convergence of capabilities and patient-centered design positions gastroenterology ASCs as a pivotal part of modern care delivery, delivering high-value, lower-cost alternatives that emphasize throughput, safety, and patient experience.

How converging clinical innovations reimbursement shifts and workforce dynamics are accelerating outpatient gastroenterology care transformation

The landscape of gastroenterology ambulatory surgery centers is undergoing transformative shifts driven by technological innovation, care delivery redesign, and workforce evolution. High-resolution imaging, capsule endoscopy, and next-generation endoscopes are improving diagnostic yield while advanced therapeutic options such as endoscopic mucosal resection, submucosal dissection, and refined polypectomy techniques are expanding the therapeutic scope possible in same-day settings. Concurrently, minimally invasive surgical approaches including laparoscopic gastrointestinal surgeries and targeted procedures like sphincterotomy and hernia repair are migrating toward outpatient platforms as perioperative protocols and anesthesia techniques reduce recovery times.

Payment reforms and value-based contracting are incentivizing site-of-care optimization, accelerating the transfer of lower-acuity, high-volume procedures from inpatient hospitals to independent ASCs and clinic-based settings. Telehealth and remote preoperative assessment tools are enhancing throughput and reducing no-show rates, while integrated electronic health records and procedural analytics enable continuous quality improvement and real-time case management. Workforce dynamics-particularly the need for advanced endoscopy-trained clinicians, perioperative nurses, and specialized technicians-are prompting investments in training and retention programs. Lastly, patient expectations for convenience, transparency, and rapid access have intensified competition, compelling providers to differentiate through care coordination, same-day surgery pathways, and enhanced recovery protocols that collectively shift the balance of care toward ambulatory environments.

Assessing the cumulative operational and procurement consequences of 2025 tariff dynamics on ambulatory gastroenterology services and capital planning

Policy shifts related to tariffs and trade in 2025 have introduced a new set of considerations for supply chains, capital planning, and procurement strategies for gastroenterology ASCs. Many diagnostic and therapeutic devices, disposables, and endoscopy accessories rely on global manufacturing networks; increases in import duties or trade frictions can raise acquisition costs and introduce variability into lead times. For providers focused on capital-intensive upgrades such as purchasing advanced endoscopes or minimally invasive surgical systems, tariff-induced cost pressures require re-evaluation of replacement cycles, leasing versus purchasing decisions, and total cost of ownership assessments.

The cumulative effect extends beyond device cost to inventory management and contracting behavior. Facilities are responding by diversifying supplier portfolios, negotiating fixed-price multi-year contracts, and exploring regional manufacturing partnerships to mitigate exposure. Independent ASCs, with typically narrower purchasing scale compared to large hospital systems, may seek group purchasing arrangements or strategic alliances to restore bargaining parity. At the same time, tariff-related price increases can accelerate consolidation as organizations pursue operational scale to absorb cost shocks. Reimbursement frameworks that do not keep pace with rising input costs will place margin pressure on lower-reimbursed procedures performed in ambulatory settings, prompting leadership to optimize case mix, enhance coding and documentation practices, and pursue higher-value therapeutic interventions that align with payer priorities. Ultimately, a strategic and differentiated supply-chain response combined with proactive financial modeling will be essential for maintaining service continuity and preserving investment in innovation under tariff uncertainty.

Integrated segmentation analysis revealing how service types indications levels of care and ownership models shape strategic priorities in gastroenterology ASCs

A nuanced segmentation view illuminates where clinical opportunity and operational focus intersect across the gastroenterology ASC landscape. When analyzed by services, diagnostic capabilities extend from capsule endoscopy and colonoscopy to esophageal manometry, flexible sigmoidoscopy, and upper endoscopy, feeding a high-throughput workflow that supports early detection and streamlined referrals. Surgical services encompass bariatric procedures, cholecystectomy, colorectal surgery, inguinal hernia repair, and a growing array of laparoscopic gastrointestinal surgeries, while therapeutic offerings such as endoscopic mucosal resection, endoscopic submucosal dissection, hemorrhoid ligation, polypectomy, and sclerotherapy create pathways for definitive outpatient care that reduce inpatient demand.

Viewing the environment through the lens of indication highlights priorities in colorectal cancer screening, gastrointestinal infections, inflammatory bowel diseases, and liver cirrhosis, each requiring distinct diagnostic algorithms, peri-procedural risk stratification, and post-procedure follow-up. The level of care axis-observation versus same-day surgery-shapes staffing patterns, recovery room design, and scheduling practices to maximize throughput while preserving patient safety. Patient demographics also drive differential service models: pediatric cases demand age-appropriate sedation and family-centered workflows, adult pathways emphasize screening and chronic disease management, and geriatric populations require comorbidity-aware preoperative evaluation and enhanced recovery protocols.

Application-driven segmentation further clarifies resource allocation between diagnostic tests, endoscopy suites, and therapeutic interventions, influencing capital expenditure priorities and clinical competency development. End-user distinctions across clinics and physicians' offices, hospitals, and independent ASCs determine referral flows, case complexity, and negotiation leverage with payers and suppliers. Finally, ownership models-corporation-owned platforms, freestanding centers, and hospital-affiliated units-affect strategic orientation toward growth, scale, and integration; each structure brings trade-offs in capital access, operational autonomy, and the ability to standardize clinical protocols. Together, these segmentation lenses provide a comprehensive framework for aligning clinical services with financial strategy and patient needs.

Comparative regional dynamics and strategic considerations shaping adoption reimbursement and capacity building across Americas EMEA and Asia-Pacific

Regional dynamics substantially influence operational models, adoption curves for advanced procedures, and regulatory-compliance requirements across the globe. In the Americas, mature reimbursement infrastructures and a strong trend toward outpatient migration have driven rapid adoption of endoscopy-focused ASCs and independent surgical centers, with particular emphasis on colorectal cancer screening programs and efficiency-driven same-day surgery workflows. North American centers often leverage consolidated purchasing and established accreditation frameworks to standardize quality and drive down per-procedure costs, while market participants experiment with bundled-payment arrangements and partnerships with payer networks.

Across Europe, the Middle East, and Africa, heterogeneous reimbursement regimes and regulatory conditions create a mosaic of adoption rates. Western European systems frequently emphasize integrated care pathways and public-private collaboration, enabling hospital-affiliated ASCs to scale diagnostic and therapeutic endoscopy programs. In contrast, emerging markets within the region present opportunities for capacity-building, technology transfer, and targeted investments in high-impact services such as management of inflammatory bowel disease and gastrointestinal infection control. Regulatory variability also influences device registration timelines and cross-border procurement strategies.

The Asia-Pacific region demonstrates rapid uptake of minimally invasive and endoscopic therapeutic techniques, driven by rising demand for elective procedures, growing geriatric populations, and expanding private healthcare infrastructure. Local manufacturing footprints are strengthening in several countries, which can mitigate exposure to international trade disruptions and support competitive pricing. However, disparities in clinician training, reimbursement reform, and urban-rural access persist, requiring tailored strategies that combine workforce development, telehealth-enabled triage, and phased capital deployment to scale ambulatory gastroenterology capabilities effectively.

Competitive dynamics and partnership strategies among device makers ASC operators and integrated health systems driving innovation and operational scale

The competitive landscape for gastroenterology ambulatory services is defined by device manufacturers, technology innovators, ASC operators, and integrated health systems that pursue scale through clinical differentiation and partnerships. Device and consumable suppliers are prioritizing durability, image clarity, and disposable options that reduce cross-contamination risk while enabling cost-effective throughput. Vendors that couple hardware with analytics, remote monitoring, and service-level agreements provide ASC operators with tools to optimize uptime and procedural efficiency.

ASC operators and health systems are responding by forging alliances with technology partners, pursuing targeted acquisitions to expand geographic reach, and investing in center-of-excellence models that concentrate complex endoscopic procedures. Strategic purchasers are also focusing on vertical integration opportunities, such as combined ambulatory networks that include preoperative assessment platforms, centralized scheduling, and standardized clinical protocols to drive consistency and economies of scale. Emerging service models emphasize joint ventures between physician groups and corporate entities to balance clinical control with capital access. Across the ecosystem, the most successful organizations are those that balance clinical innovation with disciplined operational execution, leveraging supply-chain resilience, clinician engagement, and payer relationships to sustain growth and quality.

Actionable strategic directives for executive leaders to strengthen clinical capabilities diversify supply chains and capture value in ambulatory gastroenterology

Leaders in ambulatory gastroenterology should adopt a proactive, multi-dimensional strategy to capture clinical and economic value while mitigating downside risks. First, prioritize investment in diagnostic and therapeutic endoscopy capabilities that deliver high clinical yield and procedural efficiency, supported by structured training programs to scale clinician competency. Second, diversify procurement through multi-supplier contracts, regional manufacturing partnerships, and participation in cooperative purchasing arrangements to reduce exposure to supply-side shocks and tariff-related cost volatility. Third, refine service mix and throughput by expanding same-day surgery protocols, enhancing preoperative telehealth assessments, and optimizing observation pathways to reduce length of stay without compromising safety.

Additionally, pursue partnerships with payers and health systems to develop value-based arrangements for high-volume interventions such as colorectal cancer screening and chronic disease management programs, thereby aligning incentives for quality and cost control. Invest in digital infrastructure that integrates scheduling, perioperative documentation, and analytics to monitor outcomes and identify efficiency opportunities. For ownership groups, evaluate consolidation and joint-venture models to achieve the scale necessary for competitive procurement and capital access. Finally, emphasize patient experience and transparency to strengthen referral relationships and capture market share; clear communication about procedure expectations, recovery timelines, and cost can differentiate centers in increasingly consumer-driven care pathways.

A transparent mixed-methods research methodology combining primary interviews secondary evidence and scenario analysis to produce actionable ASC insights

The research underpinning this executive summary synthesizes primary and secondary investigative approaches to ensure rigor and relevance. Primary inputs included structured interviews with clinicians, ASC administrators, supply-chain professionals, and payers, providing qualitative insights into procedural workflows, procurement priorities, and reimbursement interactions. Secondary research encompassed peer-reviewed clinical literature, regulatory guidance, device performance documentation, and public filings to corroborate clinical trends and technological capabilities.

Analytical techniques employed triangulate qualitative observations with operational metrics such as throughput, case-mix complexity, and resource utilization to generate a coherent picture of current practice patterns. Segmentation analyses were conducted across services, indications, levels of care, patient demographics, applications, end-users, and ownership structures to surface differentiated strategies appropriate to each segment. Regional comparisons drew on policy analyses and adoption indicators to map readiness across the Americas, Europe, the Middle East and Africa, and Asia-Pacific. Where uncertainty exists-particularly around trade policy and reimbursement changes-scenario-based analysis was used to outline plausible operational responses and financial sensitivities. The methodology emphasizes transparency, reproducibility, and actionable insights tailored for strategic decision-making.

Concluding synthesis on why strategic alignment clinical investment and supply chain resilience determine long-term success for gastroenterology ASCs

Ambulatory gastroenterology centers sit at the intersection of clinical innovation, operational engineering, and changing consumer expectations, presenting both significant opportunities and clear execution challenges. Advances in diagnostic and therapeutic endoscopy, coupled with improvements in perioperative care, enable a broader set of procedures to transition to same-day and observation-based models, improving access and reducing total cost of care. However, external pressures including tariff volatility, supply-chain exposure, and uneven regional reimbursement frameworks require strategic responses that balance investment in clinical capability with disciplined operational and procurement practices.

Organizations that succeed will be those that align service portfolios with population needs, invest in clinician training and digital workflows, diversify supply chains to maintain resilience, and pursue partnership structures that provide capital and scale without sacrificing clinical autonomy. By focusing on value-measured through outcomes, patient experience, and total cost-providers can position ambulatory gastroenterology centers as a preferred site of care for a growing range of diagnostic and therapeutic interventions. Thoughtful execution, rigorous quality management, and adaptive strategy will determine which centers capitalize on the shift toward outpatient gastrointestinal care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rapid adoption of advanced endoscopic imaging techniques reducing procedure times and improving outcomes
  • 5.2. Integration of artificial intelligence algorithms to enhance polyp detection and diagnostic accuracy in ambulatory centers
  • 5.3. Expansion of same-day discharge protocols supported by sedation alternatives and streamlined preoperative assessments
  • 5.4. Shift toward value based reimbursement models incentivizing quality metrics and reduced readmission rates in gastroenterology ASCs
  • 5.5. Implementation of telehealth platforms for pre and post procedure consultations boosting patient engagement and operational efficiency
  • 5.6. Investment in portable endoscopy and mobile colonoscopy units expanding access to rural and underserved patient populations

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Gastroenterology Ambulatory Surgery Center Market, by Services

  • 8.1. Diagnostic Services
    • 8.1.1. Capsule Endoscopy
    • 8.1.2. Colonoscopy
    • 8.1.3. Esophageal Manometry
    • 8.1.4. Flexible Sigmoidoscopy
    • 8.1.5. Upper Endoscopy
  • 8.2. Surgical Services
    • 8.2.1. Bariatric Surgery
    • 8.2.2. Cholecystectomy
    • 8.2.3. Colorectal Surgery
    • 8.2.4. Inguinal Hernia Repair
    • 8.2.5. Laparoscopic Gastrointestinal Surgeries
    • 8.2.6. Sphincterotomy
  • 8.3. Therapeutic Services
    • 8.3.1. Endoscopic Mucosal Resection
    • 8.3.2. Endoscopic Submucosal Dissection
    • 8.3.3. Hemorrhoid Ligation
    • 8.3.4. Polypectomy
    • 8.3.5. Sclerotherapy

9. Gastroenterology Ambulatory Surgery Center Market, by Indication

  • 9.1. Colorectal Cancer Screening
  • 9.2. Gastrointestinal Infections
  • 9.3. Inflammatory Bowel Diseases
  • 9.4. Liver Cirrhosis

10. Gastroenterology Ambulatory Surgery Center Market, by Level of Care

  • 10.1. Observation
  • 10.2. Same-Day Surgery

11. Gastroenterology Ambulatory Surgery Center Market, by Patient Demographic

  • 11.1. Adults
  • 11.2. Geriatric
  • 11.3. Pediatric

12. Gastroenterology Ambulatory Surgery Center Market, by Application

  • 12.1. Diagnostic Tests
  • 12.2. Endoscopy
  • 12.3. Therapeutic Interventions

13. Gastroenterology Ambulatory Surgery Center Market, by End-User

  • 13.1. Clinics & Physicians' Offices
  • 13.2. Hospitals
  • 13.3. Independent ASCs

14. Gastroenterology Ambulatory Surgery Center Market, by Ownership

  • 14.1. Corporation-Owned
  • 14.2. Freestanding
  • 14.3. Hospital-Affiliated

15. Gastroenterology Ambulatory Surgery Center Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Gastroenterology Ambulatory Surgery Center Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Gastroenterology Ambulatory Surgery Center Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. Competitive Landscape

  • 18.1. Market Share Analysis, 2024
  • 18.2. FPNV Positioning Matrix, 2024
  • 18.3. Competitive Analysis
    • 18.3.1. Alfa Surgery Center, LLC
    • 18.3.2. Envision Healthcare Corporation
    • 18.3.3. GE HealthCare Technologies Inc.
    • 18.3.4. Ontario Advanced Surgery Center
    • 18.3.5. Tenet Healthcare Corporation
    • 18.3.6. Universal Health Services, Inc.
    • 18.3.7. Covenant Physician Partners
    • 18.3.8. Regent Surgical
    • 18.3.9. Gastro Health LLC
    • 18.3.10. Ohio Gastroenterology Group Inc.
    • 18.3.11. HCA Healthcare, Inc.
    • 18.3.12. SCA Health
    • 18.3.13. United Digestive
    • 18.3.14. Alabama Digestive Health Endoscopy Center (AL)
    • 18.3.15. Shelby Ambulatory Surgery
    • 18.3.16. Baptist Health South Florida, Inc.
    • 18.3.17. Gulf Coast Endoscopy Center
    • 18.3.18. Jupiter Outpatient Surgery Center, LLC
    • 18.3.19. SOUTH BROWARD ENDOSCOPY, LLC
    • 18.3.20. The Outpatient Center of Boynton Beach
    • 18.3.21. Liberty Endoscopy Center
    • 18.3.22. OHIO GASTROENTEROLOGY & LIVER INSTITUTE and GASTRO HEALTH
    • 18.3.23. Inova McLean Ambulatory Surgery Center
    • 18.3.24. Gastroenterology Associates Endoscopy Center
    • 18.3.25. Athens Gastroenterology Center

LIST OF FIGURES

  • FIGURE 1. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SERVICES, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SERVICES, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LEVEL OF CARE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LEVEL OF CARE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY END-USER, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OWNERSHIP, 2024 VS 2032 (%)
  • FIGURE 15. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OWNERSHIP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AMERICAS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. NORTH AMERICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. LATIN AMERICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. EUROPE GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. MIDDLE EAST GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. AFRICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. ASEAN GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. GCC GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. EUROPEAN UNION GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BRICS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. G7 GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. NATO GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 32. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 33. GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 34. GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CAPSULE ENDOSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CAPSULE ENDOSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CAPSULE ENDOSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CAPSULE ENDOSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CAPSULE ENDOSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CAPSULE ENDOSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COLONOSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COLONOSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COLONOSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COLONOSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COLONOSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COLONOSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ESOPHAGEAL MANOMETRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ESOPHAGEAL MANOMETRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ESOPHAGEAL MANOMETRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ESOPHAGEAL MANOMETRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ESOPHAGEAL MANOMETRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ESOPHAGEAL MANOMETRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY FLEXIBLE SIGMOIDOSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY FLEXIBLE SIGMOIDOSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY FLEXIBLE SIGMOIDOSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY FLEXIBLE SIGMOIDOSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY FLEXIBLE SIGMOIDOSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY FLEXIBLE SIGMOIDOSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY UPPER ENDOSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY UPPER ENDOSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY UPPER ENDOSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY UPPER ENDOSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY UPPER ENDOSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY UPPER ENDOSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY BARIATRIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY BARIATRIC SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY BARIATRIC SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY BARIATRIC SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY BARIATRIC SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY BARIATRIC SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CHOLECYSTECTOMY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CHOLECYSTECTOMY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CHOLECYSTECTOMY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CHOLECYSTECTOMY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CHOLECYSTECTOMY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CHOLECYSTECTOMY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COLORECTAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COLORECTAL SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COLORECTAL SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COLORECTAL SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COLORECTAL SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COLORECTAL SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INGUINAL HERNIA REPAIR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INGUINAL HERNIA REPAIR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INGUINAL HERNIA REPAIR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INGUINAL HERNIA REPAIR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INGUINAL HERNIA REPAIR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INGUINAL HERNIA REPAIR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LAPAROSCOPIC GASTROINTESTINAL SURGERIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LAPAROSCOPIC GASTROINTESTINAL SURGERIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LAPAROSCOPIC GASTROINTESTINAL SURGERIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LAPAROSCOPIC GASTROINTESTINAL SURGERIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LAPAROSCOPIC GASTROINTESTINAL SURGERIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LAPAROSCOPIC GASTROINTESTINAL SURGERIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SPHINCTEROTOMY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SPHINCTEROTOMY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SPHINCTEROTOMY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SPHINCTEROTOMY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SPHINCTEROTOMY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SPHINCTEROTOMY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ENDOSCOPIC MUCOSAL RESECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ENDOSCOPIC MUCOSAL RESECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ENDOSCOPIC MUCOSAL RESECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ENDOSCOPIC MUCOSAL RESECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ENDOSCOPIC MUCOSAL RESECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ENDOSCOPIC MUCOSAL RESECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ENDOSCOPIC SUBMUCOSAL DISSECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ENDOSCOPIC SUBMUCOSAL DISSECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ENDOSCOPIC SUBMUCOSAL DISSECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ENDOSCOPIC SUBMUCOSAL DISSECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ENDOSCOPIC SUBMUCOSAL DISSECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ENDOSCOPIC SUBMUCOSAL DISSECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY HEMORRHOID LIGATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY HEMORRHOID LIGATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY HEMORRHOID LIGATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY HEMORRHOID LIGATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY HEMORRHOID LIGATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY HEMORRHOID LIGATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY POLYPECTOMY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY POLYPECTOMY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY POLYPECTOMY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY POLYPECTOMY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY POLYPECTOMY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY POLYPECTOMY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SCLEROTHERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SCLEROTHERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SCLEROTHERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SCLEROTHERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SCLEROTHERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SCLEROTHERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COLORECTAL CANCER SCREENING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COLORECTAL CANCER SCREENING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COLORECTAL CANCER SCREENING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COLORECTAL CANCER SCREENING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COLORECTAL CANCER SCREENING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COLORECTAL CANCER SCREENING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INFLAMMATORY BOWEL DISEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INFLAMMATORY BOWEL DISEASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INFLAMMATORY BOWEL DISEASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INFLAMMATORY BOWEL DISEASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INFLAMMATORY BOWEL DISEASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INFLAMMATORY BOWEL DISEASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LIVER CIRRHOSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LIVER CIRRHOSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LIVER CIRRHOSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LIVER CIRRHOSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LIVER CIRRHOSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LIVER CIRRHOSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LEVEL OF CARE, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LEVEL OF CARE, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OBSERVATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OBSERVATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OBSERVATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OBSERVATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OBSERVATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OBSERVATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SAME-DAY SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SAME-DAY SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SAME-DAY SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SAME-DAY SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SAME-DAY SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SAME-DAY SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ADULTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ADULTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ADULTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ADULTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ADULTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ADULTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY GERIATRIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PEDIATRIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC TESTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC TESTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC TESTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC TESTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC TESTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC TESTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ENDOSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ENDOSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ENDOSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ENDOSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ENDOSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ENDOSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC INTERVENTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC INTERVENTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC INTERVENTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC INTERVENTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC INTERVENTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC INTERVENTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CLINICS & PHYSICIANS' OFFICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CLINICS & PHYSICIANS' OFFICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CLINICS & PHYSICIANS' OFFICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CLINICS & PHYSICIANS' OFFICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CLINICS & PHYSICIANS' OFFICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CLINICS & PHYSICIANS' OFFICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDEPENDENT ASCS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDEPENDENT ASCS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDEPENDENT ASCS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDEPENDENT ASCS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDEPENDENT ASCS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDEPENDENT ASCS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OWNERSHIP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OWNERSHIP, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CORPORATION-OWNED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CORPORATION-OWNED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CORPORATION-OWNED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CORPORATION-OWNED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CORPORATION-OWNED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CORPORATION-OWNED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY FREESTANDING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY FREESTANDING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY FREESTANDING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY FREESTANDING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY FREESTANDING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY FREESTANDING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY HOSPITAL-AFFILIATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY HOSPITAL-AFFILIATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY HOSPITAL-AFFILIATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY HOSPITAL-AFFILIATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY HOSPITAL-AFFILIATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY HOSPITAL-AFFILIATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. AMERICAS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 250. AMERICAS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 251. AMERICAS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 252. AMERICAS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 253. AMERICAS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, 2018-2024 (USD MILLION)
  • TABLE 254. AMERICAS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVI